Sangamo Therapeutics announced the appointment of Gary H. Loeb as Executive Vice President and General Counsel, effective immediately. Loeb will oversee all legal matters for Sangamo and will report to the Chief Executive Officer.
“Gary brings dynamic experience in pharmaceutical compliance, legal operations, and executive leadership,” said Sandy Macrae, Sangamo's Chief Executive Officer. “We are pleased Gary is joining Sangamo and look forward to his contributions as Sangamo continues to grow as a clinical stage development company, and eventually into commercialization.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!
Loeb has over 20 years of experience in biotechnology and pharmaceutical law, compliance, intellectual property, litigation, human resources, regulatory, and facilities. Before joining Sangamo, he served as General Counsel, Corporate Secretary, and Chief Compliance Officer at Achaogen, an anti-infectives company. At Achaogen, Loeb was a member of the Executive Team and the first full-time in-house attorney, where he built the legal and compliance teams. Before Achaogen, Loeb worked in roles of increasing responsibility at Counsyl, a genetic screening company, Amyris, and Genentech.
Loeb received his B.S. and B.A. degrees from Stanford University and his J.D. from Columbia Law School.